Dr. Luther is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3353Fax+1 615-936-0605- Is this information wrong?
Summary
- Dr. James M. Luther is Associate Professor of medicine and pharmacology at Vanderbilt University School of Medicine in Nashville, Tennessee. The focus of his translational research program is to investigate the pathophysiologic links between hypertension and metabolic complications. His clinical focus in the Vanderbilt Hypertension Clinic is to evaluate and treat resistant and secondary hypertension. He is board certified in Medicine and Nephrology.
Dr. Luther received his MD degree from Vanderbilt School of Medicine, where he also completed training in Internal Medicine, Clinical Pharmacology, and Nephrology before joining the faculty in the Division of Clinical Pharmacology. He also received a Masters in Clinical Investigation program at Vanderbilt, and now serves as faculty in the program.
Education & Training
- Vanderbilt Univ Med Ctr2007 - 2008
- Vanderbilt Univ Med Ctr2005 - 2007
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2001 - 2004
- Vanderbilt University School of MedicineClass of 2001
Certifications & Licensure
- TN State Medical License 2003 - 2025
- AL State Medical License 2020 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Aldosterone and Glucose Homeostasis Start of enrollment: 2008 Sep 01
- Aldosterone and the Metabolic Syndrome Start of enrollment: 2010 Mar 01
- Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Flow Disturbances: Competing Interests in a Case of Hypertensive Emergency.Matthew R Alexander, Aaron W Aday, Julia Lewis, Christine J Deyholos, James M Luther> ;Hypertension. 2024 Apr 1
- 16 citationsAldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial.Luke J Laffin, David Rodman, James M Luther, Anand Vaidya, Matthew R Weir, Natasa Rajicic, B T Slingsby, Steven E Nissen> ;JAMA. 2023 Sep 26
- 2 citationsHematologic malignancies magnify the effect of body mass index on insulin resistance in cancer survivors.Melis Sahinoz, James M Luther, Mona Mashayekhi, Dae Kwang Jung, T Alp Ikizler, Brian G Engelhardt> ;Blood Advances. 2022 Apr 12
- Join now to see all
Books/Book Chapters
Press Mentions
- What's Your Approach? MRAs and Chronic Kidney DiseaseJuly 30th, 2023
- Diabetes Drug May Improve AsthmaFebruary 21st, 2023
- Medicare Reimbursement Policy for Ambulatory Blood Pressure Monitoring: A Qualitative Analysis of Public Comments to the Centers for Medicare and Medicaid ServicesDecember 1st, 2019
Grant Support
- Endogenous Aldosterone and glucose metabolismNIH/NIDDK, NHLBI2013–Present
- Role of Eicosanoids in Renal FunctionNIH/NIDDK2009–Present
- Aldosterone And Glucose MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- American Federation for Medical Research - AFMRMember
Hospital Affiliations
- Vanderbilt University Medical CenterNashville, Tennessee
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: